Rentokil Initial PLC
08 May 2003
8 May 2003
The issuer advises that the following replaces the 'Additional Listing'
announcement released yesterday, 7 May 2003, at 16:49, under RNS number 8195K.
The additional listing should refer to 1,000,000 ordinary shares of 1p and not
1,100,000 ordinary shares of 1p previously stated. All other details remain
unchanged. The full amended text appears below.
Rentokil Initial plc
-----------------------------
Application has been made to the UK Listing Authority and the London Stock
Exchange Plc for a total of 1,000,000 ordinary shares of 1p each ('shares') to
be admitted to the Official List.
It is expected that admission will be granted on 9 May 2003, and that admission
and trading will commence on 12 May 2003.
These shares are being reserved under a block listing and will be issued as a
result of the exercise of share options pursuant to the following scheme:
Scheme Shares
Rentokil Initial Share Option Scheme for UK Executives 1,000,000
When issued, these shares will rank pari passu with the existing Ordinary
shares.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.